Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ACAD
ACAD
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ACAD News
Acadia Appoints New Chief People Officer
2d ago
Newsfilter
U.S. Stocks Close Lower on Friday, Chipmakers Weigh on Market
Jun 26 2026
NASDAQ.COM
US Stock Market Under Pressure as Chip Stocks Plummet
Jun 26 2026
NASDAQ.COM
Acadia's Daybue Receives Positive Recommendation in EU
Jun 26 2026
stocktwits
Acadia Pharmaceuticals Shares Surge 12.2% on Positive Drug News
Jun 26 2026
Fool
Acadia Pharmaceuticals Shares Surge 12.2% on Positive Drug News
Jun 26 2026
NASDAQ.COM
Acadia Pharmaceuticals Receives EU Panel Endorsement for Daybu
Jun 26 2026
seekingalpha
US Stocks Decline as Chipmakers Weigh on Market
Jun 26 2026
NASDAQ.COM
Acadia Pharmaceuticals Moves Closer to EU Approval for DAYBU Therapy
Jun 26 2026
NASDAQ.COM
Acadia Pharmaceuticals' DAYBU® Receives Positive Opinion for Rett Syndrome Treatment
Jun 26 2026
Newsfilter
Trump's Policy Impact on Biopharma Innovation
May 14 2026
seekingalpha
ACADIA Pharmaceuticals Q1 2026 Earnings Call Highlights
May 07 2026
seekingalpha
Acadia (ACAD) Q1 2026 Earnings Transcript
May 06 2026
NASDAQ.COM
Acadia Pharmaceuticals to Present Multiple Data at AAN Annual Meeting
Apr 17 2026
Newsfilter
Acadia Launches DAYBUE STIX Powder for Rett Syndrome Treatment
Apr 07 2026
Newsfilter
BofA Upgrades Acadia Pharmaceuticals to Buy Amid Price Pullback
Mar 25 2026
seekingalpha
Show More News
